A similar trend is confirmed in METABRIC (Fig. 3b), with a p-value of 1 × 10−8 with log fold change of 0.1 in basal breast cancer relative to luminal and p-value 0.006 with log fold change of 0.05 in HER2+ relative to luminal. The gene discussed is ERBB2; the disease is breast carcinoma.